Aveanna Healthcare (AVAH)
(Real Time Quote from BATS)
$8.07 USD
-0.16 (-1.94%)
Updated Sep 17, 2025 02:54 PM ET
1-Strong Buy of 5 1
B Value A Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AVAH 8.07 -0.16(-1.94%)
Will AVAH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AVAH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVAH
Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
AVAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Buying the Best Top-Ranked Stocks in September
Should You Buy Aveanna Healthcare (AVAH) After Golden Cross?
Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue?
Other News for AVAH
The technical outlook for AVAH is unchanged after it falls 1.91% on September 16
Bearish Engulfing appears for AVAH after 0.59% move
Deutsche Bank Keeps Their Buy Rating on Aveanna Healthcare Holdings (AVAH)
New 52 Week Closing High appears for AVAH after 0.24% move
New 52 Week Closing High appears for AVAH after 1.94% move